Topics

pharmaceuticals

"A drug or medicine that is prepared or dispensed in pharmacies and used in medical treatment."  Compare with nutraceuticals.

Definition Source:  https://www.vocabulary.com/dictionary/pharmaceutical 

2015 Nobel Prize in Physiology or Medicine
A Combination of Ivermectin and Doxycycline Possibly Blocks the Viral Entry and Modulate the Innate Immune Response in COVID-19 Patients
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
An overview of the MATH+, I-MASK+ and I-RECOVER Protocols — A Guide to the Management of COVID-19
Antiviral Effect of Budesonide against SARS-CoV-2
Bromhexine Hydrochloride Prophylaxis of COVID-19 for Medical Personnel: A Randomized Open-Label Study
Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-Label Randomized Controlled Pilot Study
Bromhexine, for Post Exposure COVID-19 Prophylaxis: A Randomized, Double-Blind, Placebo Control Trial
Budesonide Works
Case report study of the first five COVID-19 patients treated with remdesivir in France
Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment: 62% Normalization within 24 Hours
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Covid-19 Has Turned Public Health Into a Lethal, Patient-Killing Experimental Endeavor
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
COVID-19 Treatment Guidelines - Ivermectin
Covid-19: Should doctors recommend treatments and vaccines when full data are not publicly available?
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Differential Effects of Antiseptic Mouth Rinses on SARS-CoV-2 Infectivity In Vitro
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
Down The Covid-19 Rabbit Hole: Independent Scientists And Physicians Unmask The Pandemic
Drug Industry Documents
Early Ambulatory Multidrug Therapy Reduces Hospitalization and Death in High-Risk Patients with SARS-CoV-2 (COVID-19)
Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
Expedited COVID-19 vaccine trials: a rat-race with challenges and ethical issues
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial
FMTVDM Quantitative Nuclear Imaging finds Three Treatments for SARS-CoV-2
Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity
HCQ for COVID-19: 412 studies from 8,590 scientists 529,060 patients in 58 countries
HCQ for COVID-19: real-time meta analysis of 412 studies
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
Information for Clinicians on Investigational Therapeutics for Patients with COVID-19
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Insights from a computational analysis of the SARS-CoV-2 Omicron variant: Host-pathogen interaction, pathogenicity and possible therapeutics
Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort Study
Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka – An Observational Study
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2
Ivermectin for COVID-19: Real-time meta-analysis of 99 studies
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial
Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching
Ivermectin reduces in vivo coronavirus infection in a mouse experimental model
1028